M&T Bank Corp Cuts Stock Holdings in Humana Inc. (NYSE:HUM)

M&T Bank Corp cut its holdings in Humana Inc. (NYSE:HUM - Free Report) by 13.2% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 8,437 shares of the insurance provider's stock after selling 1,288 shares during the period. M&T Bank Corp's holdings in Humana were worth $2,140,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently bought and sold shares of the stock. Ashton Thomas Securities LLC bought a new position in Humana in the 3rd quarter worth $31,000. FPC Investment Advisory Inc. purchased a new stake in shares of Humana in the fourth quarter worth about $27,000. Centricity Wealth Management LLC purchased a new position in Humana during the 4th quarter valued at approximately $30,000. Atwood & Palmer Inc. increased its stake in Humana by 64.5% in the 4th quarter. Atwood & Palmer Inc. now owns 153 shares of the insurance provider's stock worth $39,000 after acquiring an additional 60 shares during the last quarter. Finally, LRI Investments LLC lifted its position in Humana by 1,021.4% during the third quarter. LRI Investments LLC now owns 157 shares of the insurance provider's stock valued at $50,000 after purchasing an additional 143 shares during the last quarter. 92.38% of the stock is currently owned by hedge funds and other institutional investors.

Humana Stock Performance

NYSE:HUM traded up $2.07 during trading hours on Wednesday, hitting $252.27. 89,989 shares of the company were exchanged, compared to its average volume of 1,641,925. The company has a debt-to-equity ratio of 0.68, a current ratio of 1.76 and a quick ratio of 1.76. Humana Inc. has a 52-week low of $213.31 and a 52-week high of $406.46. The stock has a market capitalization of $30.44 billion, a price-to-earnings ratio of 25.35, a PEG ratio of 2.05 and a beta of 0.57. The company's 50 day moving average price is $271.67 and its 200-day moving average price is $281.65.

Remove Ads

Humana (NYSE:HUM - Get Free Report) last posted its quarterly earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. As a group, research analysts forecast that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be paid a dividend of $0.885 per share. This represents a $3.54 annualized dividend and a dividend yield of 1.40%. The ex-dividend date is Friday, March 28th. Humana's payout ratio is currently 35.58%.

Analysts Set New Price Targets

Several analysts recently weighed in on HUM shares. Royal Bank of Canada restated an "outperform" rating and set a $283.00 price target on shares of Humana in a report on Wednesday, February 12th. Morgan Stanley reduced their price objective on shares of Humana from $301.00 to $285.00 and set an "equal weight" rating on the stock in a research report on Wednesday, February 12th. Piper Sandler boosted their target price on Humana from $270.00 to $288.00 and gave the company a "neutral" rating in a research report on Wednesday, January 15th. Barclays raised their price target on Humana from $255.00 to $270.00 and gave the stock an "equal weight" rating in a research note on Thursday, February 13th. Finally, JPMorgan Chase & Co. cut their price objective on Humana from $257.00 to $256.00 and set a "neutral" rating on the stock in a research report on Tuesday, February 18th. Twenty investment analysts have rated the stock with a hold rating and five have given a buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of "Hold" and an average target price of $285.68.

Insider Activity

In related news, insider Timothy S. Huval sold 3,703 shares of Humana stock in a transaction on Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total value of $948,930.78. Following the sale, the insider now owns 8,181 shares of the company's stock, valued at approximately $2,096,463.06. This trade represents a 31.16 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 0.32% of the company's stock.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.